Weitere Artikel dieser Ausgabe durch Wischen aufrufen
Peripheral blood dyscrasias in older patients are repeatedly seen in geriatric clinical practice; however, there is substantial lack of data about the epidemiology, possible causes and treatment options in this patient group. Proton pump inhibitors (PPI) are extensively used in older patients and associated with leukopenia. The primary objective of this study was the assessment of encoded cytopenia prevalence in a geriatric patient cohort and the secondary objective was the assessment of putative causes and the analysis of PPI administration in patients with cytopenia.
Retrospective evaluation of patients admitted to the geriatric department of a German urban hospital between 2010 and 2012. Electronic patient data were screened for encoded diagnosis of cytopenia according to the International Classification of Diseases (ICD) 10. Inclusion criteria were ICD code D69.0–9 and/or D70.0–7, age ≥60 years and exclusion criteria were no ICD code D69.0–9 and/or D70.0–7 and age <60 years. Out of 9328 screened inpatients 54 patients remained for analysis. Study parameters included hemoglobin (Hb), red blood cell count (RBC), leucocytes, platelets, mean cell volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), red cell distribution width (RDW), presence of leukopenia (<4000/µl), presence of thrombocytopenia (<140,000/µl) and presence of anemia according to the World Health Organization (WHO). Substitution of blood products, medication with PPI and potential causes for dyscrasias were evaluated based on electronic patient records.
The mean age was 78.3 ± 6.5 years (27 females, 27 males), anemia was seen in 78%, leukopenia was encoded in13% and thrombocytopenia in 44.4%. In most of the patients no substitution of blood products was documented. In most of the patients (20.4%) cytopenia was attributed to either heparin-induced thrombocytopenia (HIT) or hemato-oncologic (20.4%) diseases, followed by drug association in 18.5%. In 70.8% of the study patients PPIs were administered but the indication for PPI administration remained unclear in 20.4%.
The results encourage accurate assessment of blood dyscrasias and appropriate documentation as well as indication check for PPI treatment in geriatric inpatients.
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:
Abrahamsen JF, Monsen AL, Landi F, Haugland C, Nilsen RM, Ranhoff AH (2016) Readmission and mortality one year after acute hospitalization in older patients with explained and unexplained anemia – a prospective observational cohort study. BMC Geriatr 16:109. doi: 10.1186/s12877-016-0284-4 CrossRefPubMedPubMedCentral
Bloemen A, Testroote MJ, Janssen-Heijnen ML, Janzing HM (2012) Incidence and diagnosis of heparin-induced thrombocytopenia (HIT) in patients with traumatic injuries treated with unfractioned or low-molecular-weight heparin: A literature review. Injury 43(5):548–552. doi: 10.1016/j.injury.2011.05.007 CrossRefPubMed
Chao CT, Tsai HB, Chiang CK, Huang JW (2017) COGENT (COhort of GEriatric Nephrology in NTUH) study group. Thrombocytopenia on the first day of emergency department visit predicts higher risk of acute kidney injury among elderly patients. Scand J Trauma Resusc Emerg Med 25(1):11. doi: 10.1186/s13049-017-0355-3 CrossRefPubMedPubMedCentral
Kale MS, Mhango G, Gomez JE, Sigel K, Smith CB, Bonomi M, Wisnivesky JP (2015) Treatment toxicity in elderly patients with advanced non-small cell lung cancer. Am J Clin Oncol. doi: 10.1097/COC.0000000000000188
Rodríguez-Mañas L, Gómez-Huelgas R, Veiga-Fernández F, Ruiz GM, González JM, ANCIANOS Investigators (2010) Thromboprophylaxis with the low-molecular-weight heparin bemiparin sodium in elderly medical patients in usual clinical practice: the ANCIANOS study. Clin Drug Investig 30(5):337–345. doi: 10.2165/11535460-000000000-00000 CrossRefPubMed
Röhrig G, Becker I, Schulz RJ, Lenzen-Großimlinghaus R, Willschrei P, Gebauer S, Modreker M, Jäger M, Wirth R (2016) Association between hematologic parameters and functional impairment among geriatric inpatients: Data of a prospective cross-sectional multicenter study (“GeriPrävalenz2013”). Maturitas 90:37–41. doi: 10.1016/j.maturitas.2016.04.020 CrossRefPubMed
Röhrig G, Hörter M, Becker I, Adams A, Gebauer S, Jäger M, Lenzen-Grossimlinghaus R, Modreker MK, Schulz RJ, Willschrei HP, Wirth R (2016) Anemia and hematologic parameters in older patients: Results of a German multicentric cross-sectional study. Eur Geriatr Med 7(4):328–332 CrossRef
Sherigar JM, Gayam V, Khan A, Mukhtar O, Arefiev Y, Khalid M, Siddiqui I, Rangaraju AM, Budhathoki N, Mansour M, Guss D, Mohanty SR (2017) Clinical efficacy and tolerability of direct-acting antivirals in elderly patients with chronic hepatitis C. Eur J Gastroenterol Hepatol. doi: 10.1097/MEG.0000000000000871 PubMedPubMedCentral
Zhou K, Wen F, Zhang P, Zhou J, Chen H, Zheng H, Yang Y, Li Q (2017) Efficacy and cost-effectiveness of second-line chemotherapy in elderly patients with advanced gastric cancer. Clin Transl Oncol. doi: 10.1007/s12094-017-1647-9
- Analysis of cytopenia in geriatric inpatients
MPH Dr. med. G. Röhrig
M. C. Polidori
R. J. Schulz
- Springer Medizin